Physician
General Surgery
Dr. Barry D. Kahan, MD
|
|
Give Review
Barry Kahan works in the field of General Surgery. He went to University of Chicago Pritzker School of Medicine. University of Chicago Pritzker School of Medicine has a rank of 10 in research and a 19 in primary care He has 2 awards "Elected Member" and "Fellow (FACS)". Barry D. Kahan, MD is also a published doctor. He has 46 paper published. The most recent paper is: Wojciech rowinski, a humanist and transplant surgeon, played a seminal role to establish the government-run national transplantation program in poland.
Publications
- Wojciech rowinski, a humanist and transplant surgeon, played a seminal role to establish the government-run national transplantation program in poland.
- Novel Sphingosine-1-Phosphate Receptor Modulator KRP203 Combined With Locally Delivered Regulatory T Cells Induces Permanent Acceptance of Pancreatic Islet Allografts.
- Forty years of publication of Transplantation Proceedings--the fourth decade: Globalization of the enterprise.
- YSPSL (rPSGL-Ig) for improvement of early renal allograft function: a double-blind, placebo-controlled, multi-center Phase IIa study.
- Comparing an early corticosteroid/late calcineurin-free immunosuppression protocol to a sirolimus-, cyclosporine A-, and prednisone-based regimen for pancreas-kidney t...
- Impact of reduced nephron mass on cyclosporine- and/or sirolimus-induced nephrotoxicity.
- Forty years of publication of transplantation proceedings--the second decade: the cyclosporine revolution.
- Sirolimus-based therapy for kidney transplantation from expanded criteria donors.
- Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.
- BK virus-associated nephropathy in sirolimus-treated renal transplant patients: incidence, course, and clinical outcomes.
- Interventional radiologic management of renal transplant dysfunction: indications, limitations, and technical considerations.
- Losing the kingdom: the case against commercial organ donation.
- Fokko Johannes van der Woude, 1953-2006.
- Transplantation proceedings in the second era: an organ undergoing evolution.
- Pancreas transplantation utilizing thymoglobulin, sirolimus, and cyclosporine.
- Sickle cell disease: a formidable enemy of the transplanter.
- Anesthetic rejection followed by surgical salvage.
- A comparative study of sirolimus tablet versus oral solution for prophylaxis of acute renal allograft rejection.
- Allograft rejection requires STAT5a/b-regulated antiapoptotic activity in T cells but not B cells.
- Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignancies.
- The Mannich base NC1153 promotes long-term allograft survival and spares the recipient from multiple toxicities.
- Low incidence of malignancy among sirolimus/cyclosporine-treated renal transplant recipients.
- FTY720, a novel immunomodulator: efficacy and safety results from the first phase 2A study in de novo renal transplantation.
- Selectin inhibitor bimosiamose prolongs survival of kidney allografts by reduction in intragraft production of cytokines and chemokines.
- Phase I and phase II safety and efficacy trial of intercellular adhesion molecule-1 antisense oligodeoxynucleotide (ISIS 2302) for the prevention of acute allograft re...
- The selective use of basiliximab versus thymoglobulin in combination with sirolimus for cadaveric renal transplant recipients at low risk versus high risk for delayed ...
- Metabolic interaction between cyclosporine and sirolimus.
- Prospective, randomized trial of the effect of antibody induction in simultaneous pancreas and kidney transplantation: three-year results.
- Toward calcineurin antagonist minimization.
- Selection of lowly immunogenic and highly tolerogenic donor and recipient allochimeric class I major histocompatibility complex proteins.
- Pharmacodynamics, pharmacokinetics, and safety of multiple doses of FTY720 in stable renal transplant patients: a multicenter, randomized, placebo-controlled, phase I ...
- Sirolimus does not increase the risk for postoperative thromboembolic events among renal transplant recipients.
- Dyslipidemia in renal transplant recipients treated with a sirolimus and cyclosporine-based immunosuppressive regimen: incidence, risk factors, progression, and progno...
- Thymoglobulin, sirolimus, and reduced-dose cyclosporine provides excellent rejection prophylaxis for pancreas transplantation.
- Incidence, therapy, and consequences of lymphocele after sirolimus-cyclosporine-prednisone immunosuppression in renal transplant recipients.
- Effects of sirolimus on plasma lipids, lipoprotein levels, and fatty acid metabolism in renal transplant patients.
- Allochimeric class I MHC protein-induced tolerance by partial TCR engagement requires activation of both CTL4- and common gamma-chain-dependent cytokine signals.
- Exposure-response relationships for everolimus in de novo kidney transplantation: defining a therapeutic range.
- De novo hemolytic uremic syndrome after kidney transplantation in patients treated with cyclosporine-sirolimus combination.
- 100 years ago: Ullmann's pioneering operation--autotransplantation of the kidney.
- Therapeutic drug monitoring of immunosuppressant drugs in clinical practice.
- Fortifying our monument amidst the changing landscape of transplantology.
- Update on pharmacokinetic/pharmacodynamic studies with FTY720 and sirolimus.
- Selective inhibitor of Janus tyrosine kinase 3, PNU156804, prolongs allograft survival and acts synergistically with cyclosporine but additively with rapamycin.
- Combination treatment with sirolimus and ciclosporin in clinical renal transplantation: A comprehensive review.
Schools
U Of Chgo Div Of Bio Sci Pritzker Sch Of Med
Doctors Specialties
- General Surgery
Accepted Insurances
Awards
- Elected Member
- Fellow (FACS)
Education
-
Massachusetts General Hospital -
University of Chicago Pritzker School of Medicine
Hospital
-
Baylor St. Luke's Medical Center
Helpful Reviews
Similar Doctors
|
|
Dr. John Berry Jr., MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rafik M. Ghobrial, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Penni M. Russo-Going, MD |
|
|
Dr. Victor Phuoc, MD
This Doctor is OpenDoctor Recommended.
|